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2810and procedural characteristics of study patients, but
not important post-operative risk factors. If surgery
is successful, CABG should improve postoperative
cardiac function, physical health status, and quality
of life in most of patients. It has been shown
that established preoperative risk factors are not
good predictors of adverse outcomes and long-term
survival after CABG (4). Actually, late mortality is
mainly attributable to many causes, not necessarily
related to patients’ cardiovascular and general
health before CABG. The available literature pro-
vides compelling evidence that postoperative com-
plications and persistent vital organ dysfunctions at
hospital discharge are important predictors of late
mortality after cardiac surgery (5). For example,
deep sternal wound infection or mediastinitis, acute
myocardial and kidney injuries, pulmonary com-
plications, dysfunction or loss of bypass grafts, new-
onset atrial ﬁbrillation, and deterioration of regional
wall motion after CABG have been associated inde-
pendently with increased MACE and long-term
mortality. Furthermore, hemoglobin A1c is a marker
of glycemic control over the previous 3 months before
measurement. Can preoperative hemoglobin A1c levels
exactly represent the postoperative long-term glyce-
mic control of patients? Thus, we argue that no inclu-
sion of important postoperative risk factors in the
multivariable model for adjusted hazard ratios would
have biased the true effect of preoperative glycemic
control on long-term outcomes after CABG in this
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Crit Care Med 2014;42:2069–74.REPLY: Association of Glycemic Control
in Type 1 Diabetes With Long-Term Risk
After CABGWe thank Dr. Xue and colleagues for their interest
and comments regarding our paper (1). Dr. Xue and
colleagues were concerned that the lack of informa-
tion regarding pre- and post-operative hemoglobin
levels and perioperative transfusions in our study
would have biased the results. We did not have this
information, and we agree that information regarding
pre-operative hemoglobin levels would have been
interesting because hemoglobin level has been shown
to be associated with HbA1c in patients with type 2
diabetes (2). However, because the association be-
tween hemoglobin level and HbA1c in previous
studies was very weak (2), we ﬁnd it unlikely that the
lack of information regarding preoperative hemoglo-
bin levels inﬂuenced our main ﬁndings that poor
glycemic control was associated with increased long-
term risk of death or a major adverse cardiovascular
event.
Dr. Xue and colleagues also expressed concern
regarding the variables included in the multivariable
models used to estimate adjusted hazard ratios for
the association between HbA1c categories and a
combination of death or a major adverse cardiovas-
cular event. They argued that we should have
included post-operative complications in the multi-
variable models. We disagree because control for in-
termediates (i.e., factors that are on the causal
pathway between the exposure and the outcome,
such as post-operative complications) will generally
bias estimates of the effect toward no effect (3).
Last, Dr. Xue and colleagues stated that it has been
shown that “established preoperative risk factors
are not good predictors of adverse outcomes and
long-term survival after CABG.” We wish to empha-
size that well-known cardiac surgery risk predic-
tion models, although developed for assessment of
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2811operative risk, have been demonstrated to perform
well for the prediction of long-term survival (4,5).Thomas Nyström, MD, PhD
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